状肺骨化和肺纤维化:可以减缓进展吗?
Amanda Sheena Hosein1, David Sword2
1Respiratory Medicine, NHS Ayrshire and Arran, Ayr, UK amanda_hosein@hotmail.com.
BMJ case reports
|June 19, 2025
概括
形肺部骨化 (DPO) 是罕见的. 在DPO患者中治疗阻塞性睡眠呼吸暂停 (OSA) 似乎可以稳定肺纤维化和功能,这表明这种不常见的肺部疾病的潜在管理策略.
科学领域:
- 肺部病理学 肺部病理学
- 放射学 放射学是指放射学
- 罕见疾病 罕见疾病
背景情况:
- 扩散性肺骨化 (DPO) 是一种不常见的肺部发现,具有树状和状类型.
- 关于DPO的长期预后和进展因素的数据有限.
- 由于缺乏特定的治疗方法,管理通常侧重于并发症.
研究的目的:
- 报告一例状肺骨化 (DPO) 的病例.
- 调查阻塞性睡眠呼吸暂停 (OSA) 治疗对DPO进展的潜在影响.
- 突出进一步研究和数据收集对DPO的需要.
主要方法:
- 一个中年男性与DPO的案例报告.
- 通过CT成像证实了诊断.
- 在OSA治疗后的随访期间进行肺功能测试 (PFT) 和放射性评估.
主要成果:
- 该患者被诊断患有DPO,并有喘和OSA的病史.
- 观察到PFTs的初始下降和可能的常见间歇性肺炎 (UIP) 模式纤维化的发展.
- 纤维化和PFT的稳定发生在开始OSA治疗后.
结论:
- 治疗阻塞性睡眠呼吸暂停 (OSA) 可能会减缓DPO患者纤维化和肺骨化进展.
- 需要进一步的病例报告和长期跟踪来验证这一假设.
- 建议建立DPO的国家注册表,以帮助研究和临床管理.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
297
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
297
Bone Formation by Endochondral Ossification
5.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
5.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
540
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
540
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pneumothorax-II
388
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
388


